Glenmark Pharmaceuticals board to consider unaudited financial statements

18 Jan 2013 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the company’s un-audited financial statements for the Third Quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1592.90 -33.65 (-2.07%)
09-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.10
Dr. Reddys Lab 1371.60
Cipla 1488.15
Lupin 2251.80
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.